Insider · CIK 0002023884
Nadia Waheed
officer
Files at OCUL (OCULAR THERAPEUTIX, INC). First filing Jun 3, 2025, latest Feb 24, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $210k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OCUL: OCULAR THERAPEUTIX, INC
OCULOct 9, 2026 · close 7.54
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | OCULAR THERAPEUTIX, INC | $27k 3,510 shares | -1% | +31% from low-52% from high | |
| 18Weak | OCULAR THERAPEUTIX, INC | $71k 7,863 shares | -2% | +53% from low-44% from high | |
| 20Weak | OCULAR THERAPEUTIX, INC | $112k 13,861 shares | -6% | +37% from low-29% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock10b5-1 | -3,510 | $7.74 | $27k | 314,907 | Feb 24, 2026 |
| Feb 12, 2026 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock10b5-1 | -7,863 | $9.04 | $71k | 318,417 | Feb 17, 2026 |
| Jan 2, 2026 | OCUL OCULAR THERAPEUTIX, INC | AGrant or award Common Stock | +79,112 | $0.00 | $0 | 326,280 | Jan 6, 2026 |
| Jan 2, 2026 | OCUL OCULAR THERAPEUTIX, INC | AGrant or award Stock Option (Right to Buy)derivative | +240,932 | $0.00 | $0 | 240,932 | Jan 6, 2026 |
| Aug 12, 2025 | OCUL OCULAR THERAPEUTIX, INC | AGrant or award Common Stock | +40,363 | $0.00 | $0 | 247,168 | Aug 14, 2025 |
| Aug 12, 2025 | OCUL OCULAR THERAPEUTIX, INC | AGrant or award Stock Option (Right to Buy)derivative | +122,923 | $0.00 | $0 | 122,923 | Aug 14, 2025 |
| Jun 2, 2025 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock10b5-1 | -13,861 | $8.05 | $112k | 206,805 | Jun 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.